CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Haines John R acquired 65,617 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 131,234 shares (grant or award)
- 4 Grant or award Dunn Keary acquired 16,405 shares (grant or award)
- 4 Grant or award Pres, Functional Regeneration acquired 32,809 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 41,011 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 19,686 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 16,405 shares (grant or award)
- 4 Option exercise 10% owner acquired 6,640,694 shares (option exercise)
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 10 · 191 filings